Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€39.83
20.10.21
€15.00
31.12.23
0.80%

Could be very worthwhile Investment >20% year
buy
Humana Inc.

Start price
Target price
Perf. (%)
€390.10
20.10.21
€460.00
31.12.23
1.59%

Could be very worthwhile Investment >20% year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€373.45
20.10.21
€450.00
31.12.23
1.87%

Could be very worthwhile Investment >20% year
buy
CVS Health Corp.

Start price
Target price
Perf. (%)
€74.28
20.10.21
€90.00
31.12.23
0.62%

Could be very worthwhile Investment >20% year
Novavax Inc.

Start price
Target price
Perf. (%)
€117.42
20.10.21
€105.00
20.10.22
1.69%

overvalued
Very low/no dividend yield expected
very negative Cash Flow expected
Little Investments for future growth
buy
Anthem Inc.

Start price
Target price
Perf. (%)
€363.90
20.10.21
€400.00
31.12.23
1.76%

Could be very worthwhile Investment >20% year
buy
Molina Healthcare

Start price
Target price
Perf. (%)
€237.80
21:57
€280.00
31.12.23
-

Could be very worthwhile Investment >20% year
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€2.83
20.10.21
€5.00
31.12.23
0.00%

Could be very worthwhile Investment >20% year
buy
Applied Genetic Technologies Corp.

Start price
Target price
Perf. (%)
€2.28
20.10.21
€5.00
31.12.23
0.00%

Could be very worthwhile Investment >20% year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.94
20.10.21
€35.00
31.12.23
0.60%

Could be very worthwhile Investment >20% year
buy
Qualcomm Inc.

Start price
Target price
Perf. (%)
€114.00
20.10.21
-
20.10.22
0.42%

buy
Facebook Inc. A

Start price
Target price
Perf. (%)
€292.00
19.10.21
€350.00
19.10.22
0.77%

buy
Advance Auto Parts Inc.

Start price
Target price
Perf. (%)
€193.00
19.10.21
-
19.10.22
1.04%

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Market Leader or Top 3
buy
Omeros Corp.

Start price
Target price
Perf. (%)
€5.21
19.10.21
-
19.10.22
6.68%

Could be worthwhile Investment >10% per year
buy
Automatic Data Processing Inc

Start price
Target price
Perf. (%)
€183.12
18.10.21
€190.00
18.10.22
0.90%

Could be worthwhile Investment >10% per year
buy
Facebook Inc. A

Start price
Target price
Perf. (%)
€284.50
18.10.21
€300.00
18.10.22
3.43%

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Very small cyclical dependencies
Well known brand
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.32
12:33
-
18.10.22
0.00%

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Dependend from some customers or products
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€24.07
18.10.21
€28.00
18.10.22
5.19%

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€27.09
18.10.21
-
18.10.25
6.92%

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€5.30
18.10.21
-
18.10.22
-2.36%

Risky Investment
buy
Tesla Inc

Start price
Target price
Perf. (%)
€728.10
18.10.21
-
18.10.22
5.60%

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€220.00
02.01.23
-4.38%

Could be worthwhile Investment >10% per year
buy
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€2.47
17.10.21
€4.00
31.12.23
-5.27%

Could be very worthwhile Investment >20% year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€14.60
17.10.21
€20.00
31.12.23
0.00%

Could be very worthwhile Investment >20% year
buy
J.B. Hunt Transport Services Inc.

Start price
Target price
Perf. (%)
€164.00
17.10.21
-
17.10.22
1.83%

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Capable Management
Top 10 in its market